APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Knockdown Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gene Knockdown Service Market Analysis and Forecast 2026-2032

30 January 2026193 pages

Choose your research edition.

Industry ResearchGene Knockdown Service Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Knockdown Service Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Gene Knockdown Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Knockdown Service Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Knockdown Service Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Gene Knockdown Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Gene Knockdown Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gene Knockdown Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gene Knockdown Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gene Knockdown Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Gene Knockdown Service include Altogen Labs, VectorBuilder, Creative Animodel, Creative Bioarray, Creative Biogene, Creative Biolabs, Cyagen, DefiniGEN and EditCo, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Gene Knockdown Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gene Knockdown Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Gene Knockdown Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gene Knockdown Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gene Knockdown Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Gene Knockdown Service revenue, projected growth trends, production technology, application and end-user industry.

Gene Knockdown Service Segment by Company

Altogen Labs

VectorBuilder

Creative Animodel

Creative Bioarray

Creative Biogene

Creative Biolabs

Cyagen

DefiniGEN

EditCo

GenScript

Innoprot

Integrated DNA Technologies

Sigma-Aldrich

Gene Knockdown Service Segment by Type

RNA Interference

CRISPRs

Others

Gene Knockdown Service Segment by Application

Genomics

Design Disease Models

Biopharmaceutical Research

Drug Discovery

Others

Gene Knockdown Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Knockdown Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Knockdown Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Knockdown Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Gene Knockdown Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Gene Knockdown Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Knockdown Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gene Knockdown Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. RNA Interference Major Player Table 3. CRISPRs Major Player Table 4. Others Major Player Table 5. Global Gene Knockdown Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Genomics Major Player Table 7. Design Disease Models Major Player Table 8. Biopharmaceutical Research Major Player Table 9. Drug Discovery Major Player Table 10. Others Major Player Table 11. Gene Knockdown Service Industry Trends Table 12. Gene Knockdown Service Industry Drivers Table 13. Gene Knockdown Service Industry Opportunities and Challenges Table 14. Gene Knockdown Service Industry Restraints Table 15. Global Gene Knockdown Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Gene Knockdown Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Gene Knockdown Service Market Share by Region (2021-2026) Table 18. Global Gene Knockdown Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Gene Knockdown Service Market Share by Region (2027-2032) Table 20. Global Gene Knockdown Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Gene Knockdown Service Revenue Market Share by Players (2021-2026) Table 22. Global Gene Knockdown Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Gene Knockdown Service Key Players Headquarters & Area Served Table 24. Global Gene Knockdown Service Players, Product Type & Application Table 25. Global Gene Knockdown Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Gene Knockdown Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Gene Knockdown Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Gene Knockdown Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Gene Knockdown Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Gene Knockdown Service Revenue Market Share by Type (2021-2026) Table 32. Global Gene Knockdown Service Revenue Market Share by Type (2027-2032) Table 33. Global Gene Knockdown Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Gene Knockdown Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Gene Knockdown Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Gene Knockdown Service Revenue Market Share by Application (2021-2026) Table 37. Global Gene Knockdown Service Revenue Market Share by Application (2027-2032) Table 38. Altogen Labs Company Information Table 39. Altogen Labs Business Overview Table 40. Altogen Labs Gene Knockdown Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Altogen Labs Gene Knockdown Service Product Portfolio Table 42. Altogen Labs Recent Development Table 43. VectorBuilder Company Information Table 44. VectorBuilder Business Overview Table 45. VectorBuilder Gene Knockdown Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. VectorBuilder Gene Knockdown Service Product Portfolio Table 47. VectorBuilder Recent Development Table 48. Creative Animodel Company Information Table 49. Creative Animodel Business Overview Table 50. Creative Animodel Gene Knockdown Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Creative Animodel Gene Knockdown Service Product Portfolio Table 52. Creative Animodel Recent Development Table 53. Creative Bioarray Company Information Table 54. Creative Bioarray Business Overview Table 55. Creative Bioarray Gene Knockdown Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Creative Bioarray Gene Knockdown Service Product Portfolio Table 57. Creative Bioarray Recent Development Table 58. Creative Biogene Company Information Table 59. Creative Biogene Business Overview Table 60. Creative Biogene Gene Knockdown Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Creative Biogene Gene Knockdown Service Product Portfolio Table 62. Creative Biogene Recent Development Table 63. Creative Biolabs Company Information Table 64. Creative Biolabs Business Overview Table 65. Creative Biolabs Gene Knockdown Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Creative Biolabs Gene Knockdown Service Product Portfolio Table 67. Creative Biolabs Recent Development Table 68. Cyagen Company Information Table 69. Cyagen Business Overview Table 70. Cyagen Gene Knockdown Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Cyagen Gene Knockdown Service Product Portfolio Table 72. Cyagen Recent Development Table 73. DefiniGEN Company Information Table 74. DefiniGEN Business Overview Table 75. DefiniGEN Gene Knockdown Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. DefiniGEN Gene Knockdown Service Product Portfolio Table 77. DefiniGEN Recent Development Table 78. EditCo Company Information Table 79. EditCo Business Overview Table 80. EditCo Gene Knockdown Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. EditCo Gene Knockdown Service Product Portfolio Table 82. EditCo Recent Development Table 83. GenScript Company Information Table 84. GenScript Business Overview Table 85. GenScript Gene Knockdown Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. GenScript Gene Knockdown Service Product Portfolio Table 87. GenScript Recent Development Table 88. Innoprot Company Information Table 89. Innoprot Business Overview Table 90. Innoprot Gene Knockdown Service Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Innoprot Gene Knockdown Service Product Portfolio Table 92. Innoprot Recent Development Table 93. Integrated DNA Technologies Company Information Table 94. Integrated DNA Technologies Business Overview Table 95. Integrated DNA Technologies Gene Knockdown Service Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Integrated DNA Technologies Gene Knockdown Service Product Portfolio Table 97. Integrated DNA Technologies Recent Development Table 98. Sigma-Aldrich Company Information Table 99. Sigma-Aldrich Business Overview Table 100. Sigma-Aldrich Gene Knockdown Service Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Sigma-Aldrich Gene Knockdown Service Product Portfolio Table 102. Sigma-Aldrich Recent Development Table 103. North America Gene Knockdown Service Revenue by Type (2021-2026) & (US$ Million) Table 104. North America Gene Knockdown Service Revenue by Type (2027-2032) & (US$ Million) Table 105. North America Gene Knockdown Service Revenue by Application (2021-2026) & (US$ Million) Table 106. North America Gene Knockdown Service Revenue by Application (2027-2032) & (US$ Million) Table 107. North America Gene Knockdown Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. North America Gene Knockdown Service Revenue by Country (2021-2026) & (US$ Million) Table 109. North America Gene Knockdown Service Revenue by Country (US$ Million) & (2027-2032) Table 110. Europe Gene Knockdown Service Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Gene Knockdown Service Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Gene Knockdown Service Revenue by Application (2021-2026) & (US$ Million) Table 113. Europe Gene Knockdown Service Revenue by Application (2027-2032) & (US$ Million) Table 114. Europe Gene Knockdown Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Europe Gene Knockdown Service Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Gene Knockdown Service Revenue by Country (US$ Million) & (2027-2032) Table 117. China Gene Knockdown Service Revenue by Type (2021-2026) & (US$ Million) Table 118. China Gene Knockdown Service Revenue by Type (2027-2032) & (US$ Million) Table 119. China Gene Knockdown Service Revenue by Application (2021-2026) & (US$ Million) Table 120. China Gene Knockdown Service Revenue by Application (2027-2032) & (US$ Million) Table 121. Asia Gene Knockdown Service Revenue by Type (2021-2026) & (US$ Million) Table 122. Asia Gene Knockdown Service Revenue by Type (2027-2032) & (US$ Million) Table 123. Asia Gene Knockdown Service Revenue by Application (2021-2026) & (US$ Million) Table 124. Asia Gene Knockdown Service Revenue by Application (2027-2032) & (US$ Million) Table 125. Asia Gene Knockdown Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Asia Gene Knockdown Service Revenue by Region (US$ Million) & (2021-2026) Table 127. Asia Gene Knockdown Service Revenue by Region (US$ Million) & (2027-2032) Table 128. SAMEA Gene Knockdown Service Revenue by Type (2021-2026) & (US$ Million) Table 129. SAMEA Gene Knockdown Service Revenue by Type (2027-2032) & (US$ Million) Table 130. SAMEA Gene Knockdown Service Revenue by Application (2021-2026) & (US$ Million) Table 131. SAMEA Gene Knockdown Service Revenue by Application (2027-2032) & (US$ Million) Table 132. SAMEA Gene Knockdown Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. SAMEA Gene Knockdown Service Revenue by Country (2021-2026) & (US$ Million) Table 134. SAMEA Gene Knockdown Service Revenue by Country (US$ Million) & (2027-2032) Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Gene Knockdown Service Image Figure 2. Global Gene Knockdown Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gene Knockdown Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. RNA Interference Image Figure 5. CRISPRs Image Figure 6. Others Image Figure 7. Global Gene Knockdown Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Gene Knockdown Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Genomics Image Figure 10. Design Disease Models Image Figure 11. Biopharmaceutical Research Image Figure 12. Drug Discovery Image Figure 13. Others Image Figure 14. Global Gene Knockdown Service Market Size (US$ Million) & (2021-2032) Figure 15. Global Gene Knockdown Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Gene Knockdown Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Gene Knockdown Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Gene Knockdown Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Gene Knockdown Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Gene Knockdown Service Revenue Market Share by Type (2021-2032) Figure 22. Global Gene Knockdown Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Gene Knockdown Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Gene Knockdown Service Revenue Market Share by Application (2021-2032) Figure 25. North America Gene Knockdown Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Gene Knockdown Service Revenue Share by Type (2021-2032) Figure 27. North America Gene Knockdown Service Revenue Share by Application (2021-2032) Figure 28. North America Gene Knockdown Service Revenue Share by Country (2021-2032) Figure 29. United States Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Gene Knockdown Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Gene Knockdown Service Revenue Share by Type (2021-2032) Figure 34. Europe Gene Knockdown Service Revenue Share by Application (2021-2032) Figure 35. Europe Gene Knockdown Service Revenue Share by Country (2021-2032) Figure 36. Germany Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Gene Knockdown Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Gene Knockdown Service Revenue Share by Type (2021-2032) Figure 46. China Gene Knockdown Service Revenue Share by Application (2021-2032) Figure 47. Asia Gene Knockdown Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Gene Knockdown Service Revenue Share by Type (2021-2032) Figure 49. Asia Gene Knockdown Service Revenue Share by Application (2021-2032) Figure 50. Asia Gene Knockdown Service Revenue Share by Region (2021-2032) Figure 51. Japan Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Gene Knockdown Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Gene Knockdown Service Revenue Share by Type (2021-2032) Figure 59. SAMEA Gene Knockdown Service Revenue Share by Application (2021-2032) Figure 60. SAMEA Gene Knockdown Service Revenue Share by Country (2021-2032) Figure 61. Brazil Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Gene Knockdown Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • RNA Interference
  • CRISPRs
  • Others
Applications
  • Genomics
  • Design Disease Models
  • Biopharmaceutical Research
  • Drug Discovery
  • Others
Companies covered
  • Altogen Labs
  • VectorBuilder
  • Creative Animodel
  • Creative Bioarray
  • Creative Biogene
  • Creative Biolabs
  • Cyagen
  • DefiniGEN
  • EditCo
  • GenScript
  • Innoprot
  • Integrated DNA Technologies
  • Sigma-Aldrich

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gene Knockdown Service Market by Type
  3. 1.2.1 Global Gene Knockdown Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 RNA Interference
  5. 1.2.3 CRISPRs
  6. 1.2.4 Others
  7. 1.3 Gene Knockdown Service Market by Application
  8. 1.3.1 Global Gene Knockdown Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Genomics
  10. 1.3.3 Design Disease Models
  11. 1.3.4 Biopharmaceutical Research
  12. 1.3.5 Drug Discovery
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Gene Knockdown Service Market Dynamics
  1. 2.1 Gene Knockdown Service Industry Trends
  2. 2.2 Gene Knockdown Service Industry Drivers
  3. 2.3 Gene Knockdown Service Industry Opportunities and Challenges
  4. 2.4 Gene Knockdown Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Gene Knockdown Service Market Perspective (2021-2032)
  2. 3.2 Global Gene Knockdown Service Growth Trends by Region
  3. 3.2.1 Global Gene Knockdown Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gene Knockdown Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Gene Knockdown Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Gene Knockdown Service Revenue by Players
  2. 4.1.1 Global Gene Knockdown Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Gene Knockdown Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Gene Knockdown Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gene Knockdown Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Gene Knockdown Service Key Players Headquarters & Area Served
  7. 4.4 Global Gene Knockdown Service Players, Product Type & Application
  8. 4.5 Global Gene Knockdown Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Gene Knockdown Service Market CR5 and HHI
  11. 4.6.3 2025 Gene Knockdown Service Tier 1, Tier 2, and Tier 3
5 Gene Knockdown Service Market Size by Type
  1. 5.1 Global Gene Knockdown Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Gene Knockdown Service Revenue by Type (2021-2032)
  3. 5.3 Global Gene Knockdown Service Revenue Market Share by Type (2021-2032)
6 Gene Knockdown Service Market Size by Application
  1. 6.1 Global Gene Knockdown Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Gene Knockdown Service Revenue by Application (2021-2032)
  3. 6.3 Global Gene Knockdown Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Altogen Labs
  2. 7.1.1 Altogen Labs Company Information
  3. 7.1.2 Altogen Labs Business Overview
  4. 7.1.3 Altogen Labs Gene Knockdown Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Altogen Labs Gene Knockdown Service Product Portfolio
  6. 7.1.5 Altogen Labs Recent Developments
  7. 7.2 VectorBuilder
  8. 7.2.1 VectorBuilder Company Information
  9. 7.2.2 VectorBuilder Business Overview
  10. 7.2.3 VectorBuilder Gene Knockdown Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 VectorBuilder Gene Knockdown Service Product Portfolio
  12. 7.2.5 VectorBuilder Recent Developments
  13. 7.3 Creative Animodel
  14. 7.3.1 Creative Animodel Company Information
  15. 7.3.2 Creative Animodel Business Overview
  16. 7.3.3 Creative Animodel Gene Knockdown Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Creative Animodel Gene Knockdown Service Product Portfolio
  18. 7.3.5 Creative Animodel Recent Developments
  19. 7.4 Creative Bioarray
  20. 7.4.1 Creative Bioarray Company Information
  21. 7.4.2 Creative Bioarray Business Overview
  22. 7.4.3 Creative Bioarray Gene Knockdown Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Creative Bioarray Gene Knockdown Service Product Portfolio
  24. 7.4.5 Creative Bioarray Recent Developments
  25. 7.5 Creative Biogene
  26. 7.5.1 Creative Biogene Company Information
  27. 7.5.2 Creative Biogene Business Overview
  28. 7.5.3 Creative Biogene Gene Knockdown Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Creative Biogene Gene Knockdown Service Product Portfolio
  30. 7.5.5 Creative Biogene Recent Developments
  31. 7.6 Creative Biolabs
  32. 7.6.1 Creative Biolabs Company Information
  33. 7.6.2 Creative Biolabs Business Overview
  34. 7.6.3 Creative Biolabs Gene Knockdown Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Creative Biolabs Gene Knockdown Service Product Portfolio
  36. 7.6.5 Creative Biolabs Recent Developments
  37. 7.7 Cyagen
  38. 7.7.1 Cyagen Company Information
  39. 7.7.2 Cyagen Business Overview
  40. 7.7.3 Cyagen Gene Knockdown Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Cyagen Gene Knockdown Service Product Portfolio
  42. 7.7.5 Cyagen Recent Developments
  43. 7.8 DefiniGEN
  44. 7.8.1 DefiniGEN Company Information
  45. 7.8.2 DefiniGEN Business Overview
  46. 7.8.3 DefiniGEN Gene Knockdown Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 DefiniGEN Gene Knockdown Service Product Portfolio
  48. 7.8.5 DefiniGEN Recent Developments
  49. 7.9 EditCo
  50. 7.9.1 EditCo Company Information
  51. 7.9.2 EditCo Business Overview
  52. 7.9.3 EditCo Gene Knockdown Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 EditCo Gene Knockdown Service Product Portfolio
  54. 7.9.5 EditCo Recent Developments
  55. 7.10 GenScript
  56. 7.10.1 GenScript Company Information
  57. 7.10.2 GenScript Business Overview
  58. 7.10.3 GenScript Gene Knockdown Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 GenScript Gene Knockdown Service Product Portfolio
  60. 7.10.5 GenScript Recent Developments
  61. 7.11 Innoprot
  62. 7.11.1 Innoprot Company Information
  63. 7.11.2 Innoprot Business Overview
  64. 7.11.3 Innoprot Gene Knockdown Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Innoprot Gene Knockdown Service Product Portfolio
  66. 7.11.5 Innoprot Recent Developments
  67. 7.12 Integrated DNA Technologies
  68. 7.12.1 Integrated DNA Technologies Company Information
  69. 7.12.2 Integrated DNA Technologies Business Overview
  70. 7.12.3 Integrated DNA Technologies Gene Knockdown Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Integrated DNA Technologies Gene Knockdown Service Product Portfolio
  72. 7.12.5 Integrated DNA Technologies Recent Developments
  73. 7.13 Sigma-Aldrich
  74. 7.13.1 Sigma-Aldrich Company Information
  75. 7.13.2 Sigma-Aldrich Business Overview
  76. 7.13.3 Sigma-Aldrich Gene Knockdown Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Sigma-Aldrich Gene Knockdown Service Product Portfolio
  78. 7.13.5 Sigma-Aldrich Recent Developments
8 North America
  1. 8.1 North America Gene Knockdown Service Revenue (2021-2032)
  2. 8.2 North America Gene Knockdown Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Gene Knockdown Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Gene Knockdown Service Revenue by Type (2027-2032)
  5. 8.3 North America Gene Knockdown Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Gene Knockdown Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Gene Knockdown Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Gene Knockdown Service Revenue by Application (2027-2032)
  9. 8.5 North America Gene Knockdown Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Gene Knockdown Service Revenue by Country
  11. 8.6.1 North America Gene Knockdown Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Gene Knockdown Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Gene Knockdown Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Gene Knockdown Service Revenue (2021-2032)
  2. 9.2 Europe Gene Knockdown Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Gene Knockdown Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Gene Knockdown Service Revenue by Type (2027-2032)
  5. 9.3 Europe Gene Knockdown Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Gene Knockdown Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Gene Knockdown Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Gene Knockdown Service Revenue by Application (2027-2032)
  9. 9.5 Europe Gene Knockdown Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Gene Knockdown Service Revenue by Country
  11. 9.6.1 Europe Gene Knockdown Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Gene Knockdown Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Gene Knockdown Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Gene Knockdown Service Revenue (2021-2032)
  2. 10.2 China Gene Knockdown Service Revenue by Type (2021-2032)
  3. 10.2.1 China Gene Knockdown Service Revenue by Type (2021-2026)
  4. 10.2.2 China Gene Knockdown Service Revenue by Type (2027-2032)
  5. 10.3 China Gene Knockdown Service Revenue Share by Type (2021-2032)
  6. 10.4 China Gene Knockdown Service Revenue by Application (2021-2032)
  7. 10.4.1 China Gene Knockdown Service Revenue by Application (2021-2026)
  8. 10.4.2 China Gene Knockdown Service Revenue by Application (2027-2032)
  9. 10.5 China Gene Knockdown Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gene Knockdown Service Revenue (2021-2032)
  2. 11.2 Asia Gene Knockdown Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Gene Knockdown Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Gene Knockdown Service Revenue by Type (2027-2032)
  5. 11.3 Asia Gene Knockdown Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Gene Knockdown Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Gene Knockdown Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Gene Knockdown Service Revenue by Application (2027-2032)
  9. 11.5 Asia Gene Knockdown Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Gene Knockdown Service Revenue by Country
  11. 11.6.1 Asia Gene Knockdown Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Gene Knockdown Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Gene Knockdown Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gene Knockdown Service Revenue (2021-2032)
  2. 12.2 SAMEA Gene Knockdown Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Gene Knockdown Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Gene Knockdown Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Gene Knockdown Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Gene Knockdown Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Gene Knockdown Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Gene Knockdown Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Gene Knockdown Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Gene Knockdown Service Revenue by Country
  11. 12.6.1 SAMEA Gene Knockdown Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Gene Knockdown Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Gene Knockdown Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst